Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Application of LINC00266-1 RNA as marker of solid tumors

A solid tumor and tumor diagnosis technology, applied in the direction of DNA / RNA fragments, recombinant DNA technology, microbial measurement / inspection, etc., can solve the problem of lack of tumor monitoring indicators

Active Publication Date: 2019-02-19
THE THIRD AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIVERSITY
View PDF2 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The lack of effective tumor monitoring indicators is an important reason

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of LINC00266-1 RNA as marker of solid tumors
  • Application of LINC00266-1 RNA as marker of solid tumors
  • Application of LINC00266-1 RNA as marker of solid tumors

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] RT-PCR reaction was used to detect the expression of LINC00266-1 gene in gastric cancer and liver cancer tissues.

[0045] The specific experimental plan is as follows:

[0046] 1. RNA extraction

[0047] 1) Tissue processing: Take about 10 mg of tissue and add 1 ml Trizol, homogenize with a homogenizer; centrifuge for 15 min at 12000 g, and take the supernatant.

[0048] 2) Add 200ul of chloroform to the supernatant, mix vigorously up and down for 3sec, and let stand for 3min.

[0049] 3) Centrifuge at 12,000 g for 15 minutes at 4°C. At this time, it can be seen that the lysate is divided into three layers: the upper layer is the water phase containing RNA; the middle layer is DNA, lipids, etc.; the lower layer is cell residues, proteins, polysaccharides, etc.

[0050] 4) Take the supernatant into a new EP tube; add an equal volume of isopropanol, mix well, let stand for 10 minutes, and then centrifuge at 12000g for 10 minutes at 4°C.

[0051] 5) Carefully remove th...

Embodiment 2

[0063] Q-PCR reaction was used to detect the expression of LINC00266-1 gene in gastric cancer and liver cancer tissues.

[0064] Q-PCR: GAPDH was used as an internal reference. Reaction system for Q-PCR: Add 10 μl to each reaction tube Premix Ex TaqTMII Buffer (2×), 0.8 μl forward primer, 0.8 μl reverse primer, 2 μl cDNA template prepared in Example 1, 0.4 μL ROX Reference Dye (50×), 0.2 μl Taq enzyme, add water to 20 μl . The Q-PCR reaction conditions are as follows:

[0065] ①95℃10min

[0066] ②95°C 15s

[0067] ③62℃1min

[0068] ④72°C 20s

[0069] ⑤go to②③④for 40 cycles

[0070] Primers used are listed below:

[0071]

[0072] The real-time fluorescent quantitative PCR results were analyzed in the Bio-Rad CFX Manager system software, and the amplification results were observed according to the fluorescence signal growth curve and the reaction critical cycle number (cycle threshold, Ct) given by the instrument. Using the 2-ΔΔCt value formula method to compare th...

Embodiment 3

[0074] RT-PCR reaction to detect the effect of siRNA silencing LINC00266-1 gene

[0075] (1) Digest the cells into a single-cell suspension, count, and use 5×10 5 The concentration of cells / well was inoculated into 6-well plates at 37°C, 5% CO 2 Incubate overnight in the incubator.

[0076] (2) Dissolve siALKBH1 in RNase-free deionized water to a final concentration of 20 μM, take 5 μl and dissolve in 500 μlopti-MEM, mix well, and let stand.

[0077] Wherein, the related siRNA sequence is as follows:

[0078] siLINC00266-1#1-sense:

[0079] 5′-CGUUUCACCUGCAGUUGAA TT -3' (SEQ ID NO: 7)

[0080] siLINC00266-1#1-anti-sense:

[0081] 5′-UUCAACUGCAGGUGAAACG TT -3' (SEQ ID NO: 8);

[0082] siLINC00266-1#2-sense:

[0083] 5′-CGUUUCACCUGCAGUUGAA TT -3' (SEQ ID NO: 9),

[0084] siLINC00266-1#2-anti-sense:

[0085] 5′-UUCAACUGCAGGUGAAACG TT -3' (SEQ ID NO: 10);

[0086] Negative control siRNA-sense:

[0087] 5′-GCACAAGCUGGAGUACAACUACA TT -3' (SEQ ID NO: 11),

[008...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of cancer diagnosis and treatment, and discloses an application of LINC00266-1 RNA as a general marker of solid tumors. A measurement of the LINC00266-1 RNA can be used in a detection or diagnosis of tumors, or in an evaluation and monitoring of prognosis of patients.

Description

technical field [0001] The present invention relates to the field of diagnosis and treatment of cancer, in particular to the application of LINC00266-1 RNA as a solid tumor marker. Background technique [0002] Cancer is the second leading cause of death in the world, killing approximately 8.8 million people each year. Globally, nearly one in six deaths is due to cancer. In recent years, with the improvement of people's material living standards, accelerated pace of life, changes in dietary structure, aging population, environmental pollution and other reasons, the incidence of solid malignant tumors has been increasing year by year, and it is showing a younger trend. [0003] Although the 5-year survival rate of patients with early solid malignant tumors can reach more than 80%, the rate of patients seeing a doctor is low because early solid malignant tumors have no specific symptoms and signs. Coupled with the lack of convenient and effective screening methods and the la...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6886C12N15/113
CPCC12N15/113C12Q1/6886C12N2310/14C12Q2600/118C12Q2600/178C12Q2600/166C12Q2600/158
Inventor 晏光荣王继重朱嵩
Owner THE THIRD AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com